Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

387 public trials 106 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Not Yet Recruiting

A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors

NCT06300216

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Qilu hospital of Shandong University Jinan, Shandong, China

View Trial Details

Not Yet Recruiting

Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors

NCT04889742

Conditions: Anal Cancer, Anus Diseases, Anus Neoplasms, +62 more
Locations: Klinik für Radioonkologie und Strahlentherapie Berlin, Germany

View Trial Details

Not Yet Recruiting

Evaluation of Study Experiences of Neuroendocrine Tumor Patients

NCT05967481

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Power Life Sciences San Francisco, California, United States

View Trial Details

Not Yet Recruiting

Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study

NCT04788927

Conditions: Disease Attributes, Disease Susceptibility, Genetic Predisposition to Disease, +15 more
Locations: Rigshospitalet Copenhagen, Denmark

National University Hospital, Department of Medical Endocrinology Copenhagen, Denmark

View Trial Details

Completed

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

NCT06122610

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations: University of Wisconsin - Madison Madison, Wisconsin, United States

View Trial Details

Completed

A Study of Peptide Receptor Radionuclide Therapy (PRRT) Use in Neuroendocrine Tumor (NET) Patients in Germany

NCT07653126

Conditions: Gastro-enteropancreatic Neuroendocrine Tumor, Gastro-enteropancreatic neuroendocrine tumor, Neoplasms, +5 more
Locations: Novartis Investigative Site Essen, Germany

Novartis Investigative Site Heidelberg, Germany

Novartis Investigative Site München, Germany

Novartis Investigative Site Rostock, Germany

View Trial Details

Completed

PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation

NCT02134639

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: CHU de Bordeaux Bordeaux, France

View Trial Details

Completed

Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors

NCT04510311

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Completed

A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.

NCT03910660

Conditions: Carcinoma, Carcinoma, Small Cell, Genital Diseases, +17 more
Locations: University of California San Francisco (UCSF) San Francisco, California, United States

BioXcel Clinical Research Site Denver, Colorado, United States

Yale University New Haven, Connecticut, United States

Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in GEP-NETs

NCT04727723

Conditions: Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor, Neoplasms, +5 more
Locations: Novartis Investigative Site Alessandria, Italy

Novartis Investigative Site Bologna, Italy

Novartis Investigative Site Brescia, Italy

Novartis Investigative Site Cona, Italy

View all 18 locations

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions